These regulations, which come into force on 30 March 2021, amend the Medicines Regulations 1984. The amendment to regulation 4A(4) provides a 6-month extension to the transitional period during which there is an exemption to the minimum quality standard that applies to certain CBD products of a licence holder. The transitional period now ends on 30 September 2021, and the minimum quality standard will apply on and after 1 October 2021.